{"id":2233,"date":"2021-08-08T22:42:33","date_gmt":"2021-08-08T22:42:33","guid":{"rendered":"https:\/\/oncovix.mpois.com\/?page_id=2233"},"modified":"2021-08-09T00:52:03","modified_gmt":"2021-08-09T00:52:03","slug":"centros-en-red","status":"publish","type":"page","link":"https:\/\/oncovix.mpois.com\/?page_id=2233","title":{"rendered":"Centros en red"},"content":{"rendered":"

\n
\n\n\t

El formato de atenci\u00f3n es multic\u00e9ntrico internacional, e incluye:<\/h2>\n<\/div>\n<\/div><\/div><\/div><\/div><\/section>
<\/p>\n

Evaluaci\u00f3n de admisi\u00f3n de paciente: A cargo de Consorcio Biog\u00e9nica SA. Esta etapa es de car\u00e1cter telem\u00e1tico y en ella se otorga:<\/p>\n

    \n
  • Consultor\u00eda de orientaci\u00f3n respecto a perfil, pertinencia, expectativas, complementariedad del programa.<\/li>\n
  • Informaci\u00f3n de las v\u00edas de comunicaci\u00f3n.<\/li>\n
  • Informaci\u00f3n de las etapas del proceso de postulaci\u00f3n.<\/li>\n
  • Informaci\u00f3n para recepci\u00f3n de antecedentes y ex\u00e1menes del postulante para presentaci\u00f3n a comit\u00e9 multidisciplinario de factibilidad.<\/li>\n
  • Videoconsulta de confirmaci\u00f3n de antecedentes con profesional cl\u00ednico internacional.<\/li>\n<\/ul>\n

    \n<\/div><\/div><\/div>

    <\/p>\n

    Adquisici\u00f3n del programa de atenci\u00f3n:<\/p>\n

      \n
    • Recepci\u00f3n de mail con Propuesta y Bases de programa.<\/li>\n
    • Aceptaci\u00f3n de Acta de Compliance internacional.<\/li>\n
    • Suscripci\u00f3n de dossier de inicio con ONCOCIT LLC.<\/li>\n
    • Calendarizaci\u00f3n del programa.<\/li>\n<\/ul>\n

      \n<\/div><\/div><\/div><\/div><\/div><\/section>

      \n
      \n\n\t

      Centros en red:\r\n<\/h2>\n<\/div>\n
      <\/p>\n

      Biog\u00e9nica Consorcio (Panam\u00e1; http:\/\/biogenica.org)<\/p>\n<\/p>\n

      Exolife (Espa\u00f1a ; https:\/\/www.clinicaexolife.com\/ )<\/p>\n<\/p>\n

      Inmunocell (Costa Rica; http:\/\/inmunocell.com\/ )<\/p>\n<\/p>\n

      CiCell (Panam\u00e1; http:\/\/cicellpanama.com\/ )<\/p>\n<\/p>\n

      Recell Centro Clinico (Chile ; http:\/\/recell.cl)<\/p>\n<\/p>\n

      Recell Salud (Latam; http:\/\/recellsalud.com)<\/p>\n<\/p>\n

      Oncocit (USA; http:\/\/oncocit.com)<\/p>\n<\/p>\n

      \n<\/div><\/div><\/div>

      <\/p>\n
        \n
      1. Aplicaci\u00f3n de terapia: La terapia es factible de autoaplicaci\u00f3n (similar a insulinoterapia en paciente diab\u00e9tico) a\u00fan as\u00ed, para mayor control de calidad y mejor monitoreo, cada programa incluye asistencia domiciliaria con profesional cl\u00ednico outsourcing (modelo externalizado), bajo coordinaci\u00f3n por consultora de log\u00edstica profesional nacional o internacional seg\u00fan pa\u00eds o ciudad, a cargo de Recell Salud: para procesos de coordinaci\u00f3n y log\u00edstica profesional, en ciudades de distintos pa\u00edses, donde se originan requerimientos de atenci\u00f3n, bajo atenci\u00f3n v\u00eda oficina digital, que libera de asistencia o tramites presenciales, favoreciendo una \u00e1gil y resolutiva din\u00e1mica de respuesta<\/li>\n
      2. Monitoreo de calidad de procesos cl\u00ednicos: A cargo de Recell Centro Cl\u00ednico: para procesos de control de calidad corporativa sobre din\u00e1mica de prestaciones<\/li>\n
      3. Desarrollo de algoritmos moleculares: A cargo de ONCOCIT LLC USA, que incluye algoritmos de pulsaci\u00f3n, secuenciaci\u00f3n de insumos proteicos, s\u00edntesis en biorrectarores, liofilizaciones, etc.<\/li>\n
      4. Monitoreo de calidad de procesos de laboratorio: A cargo de Flowinmunocell, que incluye un completo programa de validaci\u00f3n de insumos moleculares, viabilidad e inmunofenotipificaci\u00f3n celular, estabilidad molecular, citometria de flujo multicanal, espectrofotometr\u00eda, serolog\u00eda de interleukinas, etc.<\/li>\n
      5. Monitoreo global de programa: A cargo de OGRD Consortium, \u00fanico y \u00faltimo responsable excluyente, de toda situaci\u00f3n comercial-cl\u00ednico-legal referida a cada programa operativizado por ONCOCIT LLC USA.<\/li>\n
      6. Contralor\u00eda jur\u00eddica LATAM: A cargo de abogados en cada pa\u00eds donde se origina atenci\u00f3n, supervisados por abogado Sr Alberto Ar\u00e9valo Romero<\/li>\n<\/ol>\n

        \n<\/div><\/div><\/div><\/div><\/div><\/section><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"yoast_head":"\nCentros en red - Oncovix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Centros en red - Oncovix\" \/>\n<meta property=\"og:description\" content=\"El formato de atenci\u00f3n es multic\u00e9ntrico internacional, e incluye: Evaluaci\u00f3n de admisi\u00f3n de paciente: A cargo de Consorcio Biog\u00e9nica SA. Esta etapa es de car\u00e1cter telem\u00e1tico y en ella se otorga: Consultor\u00eda de orientaci\u00f3n respecto a perfil, pertinencia, expectativas, complementariedad del programa. Informaci\u00f3n de las v\u00edas de comunicaci\u00f3n. Informaci\u00f3n de las etapas del proceso de […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oncovix.mpois.com\/?page_id=2233\" \/>\n<meta property=\"og:site_name\" content=\"Oncovix\" \/>\n<meta property=\"article:modified_time\" content=\"2021-08-09T00:52:03+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oncovix.mpois.com\/?page_id=2233\",\"url\":\"https:\/\/oncovix.mpois.com\/?page_id=2233\",\"name\":\"Centros en red - Oncovix\",\"isPartOf\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#website\"},\"datePublished\":\"2021-08-08T22:42:33+00:00\",\"dateModified\":\"2021-08-09T00:52:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/oncovix.mpois.com\/?page_id=2233#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oncovix.mpois.com\/?page_id=2233\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oncovix.mpois.com\/?page_id=2233#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/oncovix.mpois.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Centros en red\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oncovix.mpois.com\/#website\",\"url\":\"https:\/\/oncovix.mpois.com\/\",\"name\":\"Oncovix\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oncovix.mpois.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/oncovix.mpois.com\/#organization\",\"name\":\"Oncovix\",\"url\":\"https:\/\/oncovix.mpois.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg\",\"contentUrl\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg\",\"width\":1125,\"height\":349,\"caption\":\"Oncovix\"},\"image\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Centros en red - Oncovix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_ES","og_type":"article","og_title":"Centros en red - Oncovix","og_description":"El formato de atenci\u00f3n es multic\u00e9ntrico internacional, e incluye: Evaluaci\u00f3n de admisi\u00f3n de paciente: A cargo de Consorcio Biog\u00e9nica SA. Esta etapa es de car\u00e1cter telem\u00e1tico y en ella se otorga: Consultor\u00eda de orientaci\u00f3n respecto a perfil, pertinencia, expectativas, complementariedad del programa. Informaci\u00f3n de las v\u00edas de comunicaci\u00f3n. Informaci\u00f3n de las etapas del proceso de […]","og_url":"https:\/\/oncovix.mpois.com\/?page_id=2233","og_site_name":"Oncovix","article_modified_time":"2021-08-09T00:52:03+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/oncovix.mpois.com\/?page_id=2233","url":"https:\/\/oncovix.mpois.com\/?page_id=2233","name":"Centros en red - Oncovix","isPartOf":{"@id":"https:\/\/oncovix.mpois.com\/#website"},"datePublished":"2021-08-08T22:42:33+00:00","dateModified":"2021-08-09T00:52:03+00:00","breadcrumb":{"@id":"https:\/\/oncovix.mpois.com\/?page_id=2233#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oncovix.mpois.com\/?page_id=2233"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/oncovix.mpois.com\/?page_id=2233#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/oncovix.mpois.com\/"},{"@type":"ListItem","position":2,"name":"Centros en red"}]},{"@type":"WebSite","@id":"https:\/\/oncovix.mpois.com\/#website","url":"https:\/\/oncovix.mpois.com\/","name":"Oncovix","description":"","publisher":{"@id":"https:\/\/oncovix.mpois.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oncovix.mpois.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/oncovix.mpois.com\/#organization","name":"Oncovix","url":"https:\/\/oncovix.mpois.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/","url":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg","contentUrl":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg","width":1125,"height":349,"caption":"Oncovix"},"image":{"@id":"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages\/2233"}],"collection":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2233"}],"version-history":[{"count":4,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages\/2233\/revisions"}],"predecessor-version":[{"id":2299,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages\/2233\/revisions\/2299"}],"wp:attachment":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}